欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Tyrosine Kinase-VEGFR-Semaxinib (SU5416)
Semaxinib (SU5416)

Chemical Structure : Semaxinib (SU5416)

CAS No.: 204005-46-9

Semaxinib (SU5416) (SU-5416, SU 5416)

货号: PC-42557Not For Human Use, Lab Use Only.

Semaxinib (SU5416) is a potent and specific VEGFR2 (KDR/Flk-1) inhibitor with IC50 of 1.04 uM.

规格 价格 库存 数量
10 mg ¥780 In stock
25 mg ¥1280 In stock
50 mg ¥1980 In stock
100 mg ¥2980 In stock
250 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Semaxinib (SU5416) is a potent and specific VEGFR2 (KDR/Flk-1) inhibitor with IC50 of 1.04 uM.
Semaxinib (SU5416) displays no inhibitory activity against EGFR and FGFR.
Semaxinib (SU5416) inhibits autophosphorylation of the Flk-1 receptor with IC50 of 1.23 uM in ELISA assays, inhibits VEGF-driven mitogenesis of HUVECs with IC50 of 0.04 uM.
Semaxinib (SU5416) affects tumor vascular density and vascular leakage in vivo.

物理化学性质&存储条件

分子量 238.2845
分子式 C15H14N2O
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

DMSO: 22.5 mg/mL

Chemical Name/SMILES

2H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-

参考文献

1. Fong TA, et al. Cancer Res. 1999 Jan 1;59(1):99-106.

2. Shaheen RM, et al. Cancer Res. 1999 Nov 1;59(21):5412-6.

3. Mendel DB, et al. Anticancer Drug Des. 2000 Feb;15(1):29-41.

4. Mendel DB, et al. Clin Cancer Res. 2000 Dec;6(12):4848-58.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: